Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,499 stories, page 555 of 725

Advanced search

🌍Jul 11Researchdoi.orgTier 1 · Research record

Pharmacogenomic screening strategy and indicative screening efficiency for antithyroid drug-induced agranulocytosis in the Southern Han Chinese

CrossrefOriginal source

🌍Jul 11Researchdoi.orgTier 1 · Research record

Pragmatic Clinical Trial of Fostamatinib as Second‐Line Therapy in Adult Patients With Immune Thrombocytopenia and Insufficient Response to Prior Therapy: The Fostamatinib FORTE Trial

CrossrefOriginal source

🌍Jul 11Researchdoi.orgTier 1 · Research record

Complete lesion resection and early surgical intervention are favorable factors for long‐term seizure freedom in drug‐resistant epileptic spasms

CrossrefOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Annji Pharmaceutical Co., Ltd. – TPEX:7754

TradingViewOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Sleep apnea pill maker Apnimed files for US IPO as biotech market revives

TradingViewOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Hunan Warrant Pharmaceutical Co., Ltd. Class A Stocks

TradingViewOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury | Newswise

NewswiseOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Two Preventable Semaglutide Dosing Errors May Have Driven a Surge in Poison Control Calls

Discover MagazineOriginal source

🌍Jul 11discoverynews.google.comTier 2 · Trade media

Can M&A momentum carry biotech through year-end?

BioCenturyOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Is This Biotech Stock a Buy Near Its 52-Week High?

The Motley FoolOriginal source

🌍Jul 11discoverynews.google.comTier 2 · Trade media

US FDA Proposes One Registration For Distributed Drug Manufacturing Networks

insights.citeline.comOriginal source

🌍Jul 11discoverynews.google.comTier 2 · Trade media

Apnimed files for IPO as FDA reviews its sleep apnea drug

Endpoints NewsOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Is This Biotech Stock a Buy Near Its 52-Week High?

Yahoo FinanceOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

MarketWatchOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Roche Ends Both Huntington’s Disease Drug Programs After Biomarkers Beat Patients

Tech TimesOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Partnership for Safe Medicines urges FDA advisory committee to reject compounding of unapproved peptides

Partnership for Safe MedicinesOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

LB Pharmaceuticals Grants Inducement Equity Award to New Senior Vice President of Clinical Operations

Quiver QuantitativeOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Are Projected to Extend Rally Amid Innovation and M&A

Goldman SachsOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Is There A Semaglutide Shortage? Ozempic and Wegovy Availability Updates

GoodRxOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA to Rule July 17 on Gedatolisib, First Targeted Therapy for PIK3CA Wild-Type Breast Cancer

Tech TimesOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA’s rule seeks to modernize drug manufacturing registration

PharmaLiveOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Why This Pharmaceutical Stock Jumped Close to 100% This Week

The Motley FoolOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA Proposes Rule To Simplify Drug Manufacturing Registration

tippinsightsOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA proposes drug registration changes to boost supply chain transparency

American Hospital AssociationOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

US FDA proposes rule to simplify registration for some drug manufacturers

The Mighty 790 KFGOOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Why This Pharmaceutical Stock Jumped Close to 100% This Week

Yahoo FinanceOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business

Yahoo FinanceOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Korea’s HLB fails to win FDA approval on liver cancer drug for 3rd time; stocks hit 9-month low

The Korea Economic Daily Global EditionOriginal source

🌍Jul 11discoverynews.google.comTier 2 · Trade media

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Pharmaceutical TechnologyOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment

24/7 Wall St.Original source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Chinese Biotech Taking Early-Phase Precision Medicine Trials to Australia Amid US Restrictions

Precision Medicine OnlineOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Canc

Business WireOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA's CRL Disclosure Freeze and DTC Ad Crackdown Likely Headed for Court, Sue Sutter and Derrick Gingery Warn

finance.biggo.comOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug

BenzingaOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA clears Phase II trial for rare skin disorder drug

MSNOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

AOL.comOriginal source

🌍Jul 11discoverynews.google.comTier 2 · Trade media

FDA rejects Hengrui-Elevar liver cancer drug combo for third time

Endpoints NewsOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

NMPA in China approves Heng Yi cyclosporine drop

Optometry TimesOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Recursion Pharmaceuticals Stock (RXRX) Opinions on Biotech AI Prospects

Quiver QuantitativeOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA Approves Subcutaneous Sarclisa Escena | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

OKYO's urcosimod gets FDA nod, moves to global phase 3 trial for NCP

Eyes On EyecareOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

RegenxBio doses first patient in phase 2b/3 trial for DR

Eyes On EyecareOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (TSE:4502) Taps Pharma.AI For Drug Discovery, Is The Stock Still Cheap?

simplywall.stOriginal source

🇺🇰Jul 11Regulatorygov.ukTier 1 · Regulatory source

Ministers launch crackdown on vapes targeting kids

Ministers have launched a crackdown on vapes marketed at kids with a shift to plain white packaging.

UK Department of Health and Social CareOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Bhiwandi Food Safety Drive: BNCMC, FDA To Crack Down On Illegal Food Businesses After Mass Food Poisoning

Free Press JournalOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

Applied Clinical Trials OnlineOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Forte Biosciences' Vitiligo Triumph: A High-Stakes Bet on Broad Autoimmune Potential

Kavout | AIOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

FDA Approves Perioperative Pembro Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

Oncology News CentralOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Clinical Trials ArenaOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal

RTTNewsOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks To Keep An Eye On - July 10th

MarketBeatOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Yahoo FinanceOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical marketplaces: How online platforms are changing drug purchasing

Caledonian RecordOriginal source

🌍Jul 11discoverynews.google.comTier 3 · Aggregated media

HLB, Hengrui receive third US FDA rejection on liver cancer combo

BioWorld NewsOriginal source

🌍Jul 11discoverynews.google.comTier 2 · Trade media

'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive

Endpoints NewsOriginal source

🌍Jul 10discoverynews.google.comTier 2 · Trade media

GSK, Hansoh ADC extends survival in lung cancer study

BioPharma DiveOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs

Yahoo Finance SingaporeOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 500,000 shares, representing 1.73% for ¥625 million.

marketscreener.comOriginal source

🇺🇰Jul 10Regulatorygov.ukTier 1 · Regulatory source

The benefits of physical activity at all stages of life for health

Professor Chris Whitty writes for The i paper on the update to the UK CMOs' physical activity guidel...

UK Department of Health and Social CareOriginal source

🌍Jul 10discoverynews.google.comTier 3 · Aggregated media

Big changes ahead for Oregon’s psilocybin agency, New bill seeks to turn Trump’s psychedelics executive order into permanent law

The MicrodoseOriginal source